Jim Simons Hcw Biologics Inc. Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 15,000 shares of HCWB stock, worth $5,850. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$5,850% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding HCWB
# of Institutions
19Shares Held
3.13MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY2.02MShares$789,2280.01% of portfolio
-
Avantax Planning Partners, Inc.280KShares$109,0200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA182KShares$70,9630.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$70,5150.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$51,4760.0% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...